Literature DB >> 26421447

The Stimulatory Effect of Notochordal Cell-Conditioned Medium in a Nucleus Pulposus Explant Culture.

Stefan A H de Vries1, Marina van Doeselaar1, Björn P Meij2, Marianna A Tryfonidou2, Keita Ito1,3.   

Abstract

OBJECTIVES: Notochordal cell-conditioned medium (NCCM) has previously shown to have a stimulatory effect on nucleus pulposus cells (NPCs) and bone marrow stromal cells (BMSCs) in alginate and pellet cultures. These culture methods provide a different environment than the nucleus pulposus (NP) tissue, in which the NCCM ultimately should exert its effect. The objective of this study is to test whether NCCM stimulates NPCs within their native environment, and whether combined stimulation with NCCM and addition of BMSCs has a synergistic effect on extracellular matrix production.
METHODS: Bovine NP tissue was cultured in an artificial annulus in base medium (BM), porcine NCCM, or BM supplemented with 1 μg/mL Link N. Furthermore, BM and NCCM samples were injected with 10(6) BMSCs per NP sample. Samples were cultured for 4 weeks, and analyzed for biochemical contents (water, glycosaminoglycan [GAG], hydroxyproline, and DNA), gene expression (COL1A1, COL2A1, ACAN, and SOX9), and histology by Safranin O/Fast Green staining.
RESULTS: Culture in NCCM resulted in increased proteoglycan content compared to day 0 and BM, similar to Link N. However, only minor differences in gene expression compared to day 0 were observed. Addition of BMSCs did not result in increased GAG content, and surprisingly, DNA content in BMSC-injected groups was not higher than in the other groups after 4 weeks of culture. DISCUSSION: This study shows that, indeed, NCCM is capable of stimulating NPC matrix production within the NP environment. The lack of increased DNA content in the BMSC-injected groups indicates that BMSCs have died over time. Identification of the bioactive factors in NCCM is crucial for further development of an NCCM-based treatment for intervertebral disc regeneration.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26421447     DOI: 10.1089/ten.TEA.2015.0121

Source DB:  PubMed          Journal:  Tissue Eng Part A        ISSN: 1937-3341            Impact factor:   3.845


  13 in total

1.  Hyperosmolarity induces notochordal cell differentiation with aquaporin3 upregulation and reduced N-cadherin expression.

Authors:  Paolo E Palacio-Mancheno; Thomas W Evashwick-Rogler; Damien M Laudier; Devina Purmessur; James C Iatridis
Journal:  J Orthop Res       Date:  2017-09-20       Impact factor: 3.494

2.  Differentiation of human induced pluripotent stem cells into nucleus pulposus-like cells.

Authors:  Ruhang Tang; Liufang Jing; Vincent P Willard; Chia-Lung Wu; Farshid Guilak; Jun Chen; Lori A Setton
Journal:  Stem Cell Res Ther       Date:  2018-03-09       Impact factor: 6.832

3.  Notochordal-cell derived extracellular vesicles exert regenerative effects on canine and human nucleus pulposus cells.

Authors:  Frances Bach; Sten Libregts; Laura Creemers; Björn Meij; Keita Ito; Marca Wauben; Marianna Tryfonidou
Journal:  Oncotarget       Date:  2017-10-04

4.  Co-culturing nucleus pulposus mesenchymal stem cells with notochordal cell-rich nucleus pulposus explants attenuates tumor necrosis factor-α-induced senescence.

Authors:  Xiao-Chuan Li; Mao-Sheng Wang; Wei Liu; Cheng-Fan Zhong; Gui-Bin Deng; Shao-Jian Luo; Chun-Ming Huang
Journal:  Stem Cell Res Ther       Date:  2018-06-26       Impact factor: 6.832

5.  Human notochordal cell transcriptome unveils potential regulators of cell function in the developing intervertebral disc.

Authors:  Ricardo Rodrigues-Pinto; Lizzy Ward; Matthew Humphreys; Leo A H Zeef; Andrew Berry; Karen Piper Hanley; Neil Hanley; Stephen M Richardson; Judith A Hoyland
Journal:  Sci Rep       Date:  2018-08-27       Impact factor: 4.379

6.  An optimized culture system for notochordal cell expansion with retention of phenotype.

Authors:  Matthew D Humphreys; Lizzy Ward; Stephen M Richardson; Judith A Hoyland
Journal:  JOR Spine       Date:  2018-07-26

Review 7.  Notochordal Cell-Based Treatment Strategies and Their Potential in Intervertebral Disc Regeneration.

Authors:  Frances C Bach; Deepani W Poramba-Liyanage; Frank M Riemers; Jerome Guicheux; Anne Camus; James C Iatridis; Danny Chan; Keita Ito; Christine L Le Maitre; Marianna A Tryfonidou
Journal:  Front Cell Dev Biol       Date:  2022-03-14

8.  An Inflammatory Nucleus Pulposus Tissue Culture Model to Test Molecular Regenerative Therapies: Validation with Epigallocatechin 3-Gallate.

Authors:  Olga Krupkova; Marian Hlavna; Julie Amir Tahmasseb; Joel Zvick; Dominik Kunz; Keita Ito; Stephen J Ferguson; Karin Wuertz-Kozak
Journal:  Int J Mol Sci       Date:  2016-09-27       Impact factor: 5.923

9.  Biologic canine and human intervertebral disc repair by notochordal cell-derived matrix: from bench towards bedside.

Authors:  Frances C Bach; Anna R Tellegen; Martijn Beukers; Alberto Miranda-Bedate; Michelle Teunissen; Willem A M de Jong; Stefan A H de Vries; Laura B Creemers; Karin Benz; Björn P Meij; Keita Ito; Marianna A Tryfonidou
Journal:  Oncotarget       Date:  2018-05-29

Review 10.  Mitochondrial quality control in intervertebral disc degeneration.

Authors:  Yu Song; Saideng Lu; Wen Geng; Xiaobo Feng; Rongjin Luo; Gaocai Li; Cao Yang
Journal:  Exp Mol Med       Date:  2021-07-16       Impact factor: 12.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.